LRE Medical GmbH (LRE) announces that the acquisition of the company by Gyrus Capital was successfully completed on August 1, 2023. LRE now achieved the status of an independent company and is in the early stages of promising growth under the support of Gyrus Capital, an international investment firm based in Geneva, Switzerland. Gyrus Capital specializes in healthcare and medical technology investments.
The management team of LRE is excited about the promising cooperation with the new owners. Together we will further develop and enable future growth.
We would also like to thank our former owners, KPS Capital Partners, for the close partnership and collaboration during the last 3.5 years. During this highly successful period, LRE has seen impressive growth in both revenue and earnings. In particular, important technological investments were made, such as in the CNC machine in Munich and the state-of-the-art SMD facility in Nördlingen. These investments have significantly strengthened LRE’s technological base and have made the company well prepared for future innovations and developments.
LRE is confident that the promising partnership with Gyrus Capital will further accelerate its growth strategy. This will help LRE to take a leading position in the global diagnostics market and further consolidate its position as an innovation leader in medical technology.